ClinConnect ClinConnect Logo
Search / Trial NCT02182921

Evaluation of Cataract Surgery Outcome

Launched by EVIDENCE BASED CATARACT STUDY GROUP · Jul 7, 2014

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the outcomes of cataract surgery in patients with cataracts and high myopia (a condition where distant objects appear blurry). The main goal is to see how well participants can see after the surgery, including both their best vision without glasses and with glasses, as well as other measurements related to their vision.

To be eligible for this study, participants need to have a clinical diagnosis of cataracts and should be able to cooperate during eye exams. Unfortunately, individuals with a clinical diagnosis of mental illness or those who are mentally disabled cannot participate. If you decide to join the trial, you can expect to undergo various eye tests before and after your cataract surgery to help researchers understand the surgery's effectiveness. The trial is currently looking for participants of all ages, so if you or a loved one fit the criteria, this could be a valuable opportunity to contribute to important research in eye health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical diagnosis of cataract
  • Must be able to cooperate with the ophthalmic examination
  • Exclusion Criteria:
  • Clinical diagnosis of mental illness
  • Mentally disabled

About Evidence Based Cataract Study Group

The Evidence-Based Cataract Study Group is a dedicated clinical trial sponsor focused on advancing the understanding and treatment of cataracts through rigorous research. Committed to improving patient outcomes, the group conducts comprehensive studies that integrate evidence-based methodologies to evaluate the efficacy and safety of various cataract interventions. By fostering collaboration among leading ophthalmologists and researchers, the Evidence-Based Cataract Study Group aims to generate high-quality data that informs clinical practice and enhances the quality of care for individuals affected by cataracts.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Trial Officials

Yi Lu, MD

Study Chair

Eye and ENT Hospital of Fudan University

Xiangjia Zhu, MD

Study Director

Eye and ENT Hospital of Fudan University

Jin Yang, MD

Study Director

Eye and ENT Hospital of Fudan University

Keke Zhang, MD

Principal Investigator

Eye and ENT Hospital of Fudan University

Wenwen He, MD

Principal Investigator

Eye and ENT Hospital of Fudan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials